-
摘要: 三尖瓣反流是一种进展性疾病, 普遍存在于健康人群和器质性心脏病患者, 其治疗是心脏手术中具有挑战性的难题, 目前主要以外科手术为主。对于一些高龄且有多种并发症的患者, 外科开胸手术治疗的风险很大。近年来, 关于三尖瓣反流的介入治疗已逐渐成为心脏瓣膜治疗的新热点。Abstract: Tricuspid regurgitation is a progressive disease that usually occurs on healthy people and patients with organic heart disease.Surgery is still the main method to cure the disease but remains challenge.Open-heart surgery carries the risk for some elderly or patients with multiple complications.In recent years, the interventional treatment of tricuspid regurgitation has gradually become a new hot spot in the treatment of valvular heart disease.
-
Key words:
- tricuspid regurgitation /
- interventional therapy
-
-
[1] Vahanian A, Juliard JM, Brochet E.When surgery is not an option:is there a clinical need for transcatheter tricuspid valve therapies?[J].Minerva Cardioangiol, 2017, 65 (5):500-503.
[2] Sevimli S, Aksakal E, Tanboga IH, et al.Percutaneous valve-in-valve transcatheter tricuspid valve replacement with simultaneous paravalvular leak closure in a patient with refractory right heart failure[J].JACCCardiovasc Interv, 2014, 7 (7):e79-e80.
[3] Medvedofsky D, Aronson D, Gomberg-Maitland M, et al.Tricuspid regurgitation progression and regression in pulmonary arterial hypertension:implications for right ventricular and tricuspid valve apparatus geometry and patients outcome[J].Eur Heart J Cardiovasc Imaging, 2017, 18 (1):86-94.
[4] Toyama K, Ayabe K, Kar S, et al.Postprocedural Changes of Tricuspid Regurgitation After MitraClip Therapy for Mitral Regurgitation[J].Am J Cardiol, 2017, 120 (5):857-861.
[5] Coffey S, Rayner J, Newton J, et al.Right-sided valve disease[J].Int J Clin Pract, 2014, 68 (10):1221-1226.
[6] Ohno Y, Attizzani GF, Capodanno D, et al.Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System:30-day and 12-month follow-up from the GRASP Registry[J].Eur Heart JCardiovasc Imaging, 2014, 15 (11):1246-1255.
[7] Cho JY, Kim KH, Kim JY, et al.Predictors of reversible severe functional tricuspid regurgitation in patients with atrial fibrillation[J].J Cardiol, 2016, 68 (5):419-425.
[8] Gafoor S, Petrescu OM, Lehr EJ, et al.Percutaneous tricuspid valve regurgitation repair with the mitraclip device using an edge-to-edge bicuspidization technique[J].J Invasive Cardiol, 2017, 29 (3):E30-E36.
[9] Owais K, Taylor CE, Jiang L, et al.Tricuspid annulus:a three-dimensional deconstruction and reconstruction[J].Ann Thorac Surg, 2014, 98 (5):1536-1542.
[10] Agarwal S, Tuzcu EM, Rodriguez ER, et al.Interventional cardiology perspective of functional tricuspid regurgitation[J].Circ Cardiovasc Interv, 2009, 2 (6):565-573.
[11] Lauten A, Ferrari M, Figulla HR.Letter by Lauten et al regarding article, "Interventional cardiology perspective of functional tricuspid regurgitation"[J].Circ Cardiovasc Interv, 2010, 3 (3):e10, e11.
[12] Jang JY, Heo R, Lee S, et al.Comparison of Results of Tricuspid Valve Repair Versus Replacement for Severe Functional Tricuspid Regurgitation[J].Am JCardiol, 2017, 119 (6):905-910.
[13] Nurozler F, Kutlu T, Kucuk G.Association of edge-toedge repair to De Vega annuloplasty for tricuspid incompetence[J].Scand Cardiovasc J, 2007, 41 (3):192-196.
[14] Hammerstingl C, Schueler R, Malasa M, et al.Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system[J].Eur Heart J, 2016, 37 (10):849-853.
[15] Hahn RT.Transcathether valve replacement and valve repair:review of procedures and intraprocedural echocardiographic imaging[J].Circ Res, 2016, 119 (2):341-356.
[16] Alozie A, Westphal B, Kische S, et al.Surgical revision after percutaneous mitral valve repair by edge-to-edge device:when the strategy fails in the highest risk surgical population[J].Eur J Cardiothorac Surg, 2014, 46 (1):55-60.
[17] Hahn RT, Meduri CU, Davidson CJ, et al.Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty:SCOUT Trial 30-Day Results[J].J Am Coll Cardiol, 2017, 69 (14):1795-1806.
[18] Taramasso M, Nietlispach F, Zuber M, et al.Transcatheter repair of persistent tricuspid regurgitation after MitraClip with the TriCinch system:interventional valve treatment toward the surgical standard[J].Eur Heart J, 2017, 38 (16):1259.
[19] Calen C, Taramasso M, Guidotti A, et al.Successful TriCinch-in-TriCinch Transcatheter Tricuspid Valve Repair[J].JACC Cardiovasc Interv, 2017, 10 (8):e75-e77.
[20] Puri R, Rodes-Cabau J.Transcatheter interventions for tricuspid regurgitation:the FORMA Repair System[J].EuroIntervention, 2016, 12 (Y):Y113-Y115.
[21] Lauten A, Figulla HR, Willich C, et al.Percutaneous caval stent valve implantation:investigation of an interventional approach for treatment of tricuspid regurgitation[J].Eur Heart J, 2010, 31 (10):1274-1281.
[22] Lauten A, Figulla HR, Willich C, et al.Heterotopic valve replacement as an interventional approach to tricuspid regurgitation[J].J Am Coll Cardiol, 2010, 55 (5):499-500.
[23] Lauten A, Ferrari M, Hekmat K, et al.Heterotopic transcatheter tricuspid valve implantation:first-in-man application of a novel approach to tricuspid regurgitation[J].Eur Heart J, 2011, 32 (10):1207-1213.
[24] Vahanian A, Juliard JM.When transcatheter therapy moves to the "forgotten valve"[J].J Am Coll Cardiol, 2015, 66 (22):2484-2486.
[25] Lauten A, Laube A, Schubert H, et al.Transcatheter treatment of tricuspid regurgitation by caval valve implantation——experimental evaluation of decellularized tissue valves in central venous position[J].Catheter Cardiovasc Interv, 2015, 85 (1):150-160.
[26] Amerini A, Hatam N, Malasa M, et al.A personalized approach to interventional treatment of tricuspid regurgitation:experiences from an acute animal study[J].Interact Cardiovasc Thorac Surg, 2014, 19 (3):414-418.
-
计量
- 文章访问数: 154
- PDF下载数: 125
- 施引文献: 0